ANGELA LAWSON: Open Payments
NPI 1124580485 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 8 payments from 5 companies in 2025. Trend: 2023 $118 · 2024 $21 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| PFIZER INC. | 1 | $22 |
| GENZYME CORPORATION | 1 | $20 |
| Pulmonx Corporation | 1 | $17 |
Products named: GLASSIA, TEZSPIRE, FASENRA, ELIQUIS, DUPIXENT, CHARTIS CATHETER.
Industry payments across IN — which companies pay providers there.
